Inventor · disambiguated record
Nikolai Naryshkin
Also filed as: NARYSHKIN NIKOLAI · NARYSHKIN NIKOLAI A
27 granted patents·14 pending applications·203 citations·filing 2004–2023
96Inventor score
Files withPTC THERAPEUTICS INC27HOFFMANN LA ROCHE6PAUSHKIN SERGEY V3FLAGSHIP PIONEERING INNOVATIONS VI LLC2CAO LIANGXIAN1
Top patents by PatentIndex Score
41 records- 0197US9969754B2Compounds for treating spinal muscular atrophyHOFFMANN LA ROCHE·Filed 2016·Granted May 15, 2018·25 cites·38 claims
- 0295US9879007B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2016·Granted Jan 30, 2018·18 cites·4 claims
- 0395US8633019B2Methods for treating spinal muscular atrophyPAUSHKIN SERGEY V·Filed 2009·Granted Jan 21, 2014·38 cites·7 claims
- 0494US9617268B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2012·Granted Apr 11, 2017·32 cites·5 claims
- 0594US9586955B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2013·Granted Mar 7, 2017·22 cites·21 claims
- 0693US11827646B2Compounds for treating spinal muscular atrophyHOFFMANN LA ROCHE·Filed 2020·Granted Nov 28, 2023·2 cites·24 claims
- 0793US9399649B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2013·Granted Jul 26, 2016·34 cites·11 claims
- 0891US10882868B2Compounds for treating spinal muscular atrophyHOFFMANN LA ROCHE·Filed 2018·Granted Jan 5, 2021·4 cites·13 claims
- 0987US10195202B2Methods for modulating the amount of RNA transcriptsPTC THERAPEUTICS INC·Filed 2014·Granted Feb 5, 2019·4 cites·8 claims
- 1086US8741572B1Methods of screening for compounds for treating muscular dystrophy using mIGF1 mRNA translation regulationPTC THERAPEUTICS INC·Filed 2012·Granted Jun 3, 2014·5 cites·16 claims
- 1184US2024067646A1Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1283US2024076302A1Compounds for treating spinal muscular atrophyHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1380US8283115B1Methods of screening for compounds for treating muscular dystrophy using UTRN mRNA translation regulationFRIESEN WESTLEY J·Filed 2008·Granted Oct 9, 2012·7 cites·12 claims
- 1479US10668171B2Methods for modulating RNA splicingPTC THERAPEUTICS INC·Filed 2016·Granted Jun 2, 2020·1 cites·22 claims
- 1579US8932818B2Screening assays for compounds that modulate programmed ribosomal frameshiftingPAUSHKIN SERGEY V·Filed 2009·Granted Jan 13, 2015·2 cites·16 claims
- 1678US10501482B2Compounds for treating spinal muscular atrophyHOFFMANN LA ROCHE·Filed 2018·Granted Dec 10, 2019·2 cites·31 claims
- 1777US12398140B2Substituted pyrrolo [2,3-d]pyrimidines for treating familial dysautonomiaPTC THERAPEUTICS INC·Filed 2020·Granted Aug 26, 2025·1 cites·13 claims
- 1876US12384797B2Thioeno[3,2-b] pyridin-7-amine compounds for treating familial dysautonomiaPTC THERAPEUTICS INC·Filed 2020·Granted Aug 12, 2025·1 cites·17 claims
- 1976US2023310651A1Methods for modulating rna splicingPTC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2075US8986935B2Methods for treating spinal muscular atrophyPAUSHKIN SERGEY V·Filed 2009·Granted Mar 24, 2015·1 cites·9 claims
- 2173US9376725B1Methods of screening for compounds for treating muscular dystrophy using human ALPHA7 integrin mRNA translation regulationPTC THERAPEUTICS INC·Filed 2014·Granted Jun 28, 2016·1 cites·16 claims
- 2271US11753407B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2020·Granted Sep 12, 2023·0 cites·13 claims
- 2371US10851101B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2019·Granted Dec 1, 2020·0 cites·9 claims
- 2470US11602567B2Methods for modulating RNA splicingPTC THERAPEUTICS INC·Filed 2020·Granted Mar 14, 2023·0 cites·14 claims
- 2568US11608501B2Methods for modifying RNA splicingPTC THERAPEUTICS INC·Filed 2018·Granted Mar 21, 2023·1 cites·17 claims
- 2668US2023272367A1Methods for modulating rna splicingPTC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2763US2018105526A1Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2859US2015344877A1Methods for treating viral infectionsPTC THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2958US2015283115A1Methods for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3058US2024401047A1Trem compositions and methods of useFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 3158US2014135305A1Methods for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3256US10688099B2Methods for modulating the amount of RNA transcriptsPTC THERAPEUTICS INC·Filed 2019·Granted Jun 23, 2020·0 cites·7 claims
- 3356US2025295687A1Trem compositions and methods of use for treating proliferative disordersFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Application pending·0 cites
- 3455US9068234B2Methods and agents for screening for compounds capable of modulating gene expressionCAO LIANGXIAN·Filed 2004·Granted Jun 30, 2015·2 cites·17 claims
- 3553US2023172915A1Dhodh inhibitor for the treatment of covid-19PTC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3652US11702646B2Methods for modulating RNA splicingPTC THERAPEUTICS INC·Filed 2017·Granted Jul 18, 2023·0 cites·9 claims
- 3752US2023047208A1RNA Splicing ModulationMASSACHUSETTS GEN HOSPITAL·Filed 2021·Application pending·0 cites
- 3851US9476870B2Methods and agents for screening for compounds capable of modulating gene expressionPTC THERAPEUTICS INC·Filed 2015·Granted Oct 25, 2016·0 cites·15 claims
- 3951US2016145270A1Compounds for treating spinal muscular atrophyHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 4050USRE47689ECompounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2012·Granted Nov 5, 2019·0 cites·7 claims
- 4148US2023057568A1Compounds for treating familial dysautonomiaPTC THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nikolai Naryshkin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →